Moneycontrol PRO
X

companies

3 Point Analysis | Will AstraZeneca’s paused COVID-19 vaccine trial impact the ongoing trials in India?

Moneycontrol's Sakshi Batra does a 3 Point Analysis to find out the reasons behind the pause of the trial and how will this impact India

first published: Sep 9, 2020 09:05 pm

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347
CloseOutskill Genai